Systematically altering the lipophilicity of rhenium(i) tricarbonyl anticancer agents to tune the rate at which they induce cell death
Abstract
Increasing the lipophilicity of rhenium-based anticancer agents increases the rate at which they induce their biological effects.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2020
- Source ID
- 10.1039/d0dt01097a
Entities
People
- Brett A. Vaughn
- Chilaluck C Konkankit
- Eszter Boros
- Justin J. Wilson
- Zhouyang Huang
Organizations
- Congressionally Directed Medical Research Programs
- Cornell University
- Cornell University College of Arts and Sciences
- Division of Chemistry
- National Heart, Lung, and Blood Institute
- Stony Brook University
- United States Army
- Yusuf Hamied Department of Chemistry